Kunlatida Maneenil

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 312 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Sarcomatoid Carcinoma of the Lung: The Mayo Clinic Experience in 127 Patients

Kunlatida Maneenil, Zhiqiang Xue, Ming Liu et al. · Clinical Lung Cancer · 2017 · 98 citations

Medicine, Oncology, Surgery +14

A randomized, double-blind, placebo-controlled study evaluating the efficacy of combination olanzapine, ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving doxorubicin plus cyclophosphamide

Piyawan Tienchaiananda, Wipada Nipondhkit, Kunlatida Maneenil et al. · Annals of Palliative Medicine · 2019 · 40 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Factors influencing development and mortality of acute respiratory failure in hospitalized patient with active pulmonary tuberculosis: a 10-year retrospective review

Rungsun Bhurayanontachai, Kunlatida Maneenil · Journal of Thoracic Disease · 2016 · 24 citations · Full text

Medicine, Infectious Diseases, Clinical Epidemiology +10